Lilly Reports First-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Eli Lilly (LLY) PT Lowered to $92 at Jefferies; Reiterates Buy
April 26, 2017 9:10 AM EDTJefferies lowered its price target on Eli Lilly (NYSE: LLY) to $92.00 (from $94.00) while maintaining a Buy rating. Jefferies lowered EPS estimates by up to 7% mid term and are now mostly in line with consensus over the next few years.
Jefferies' revenue estimates... More
